Barclays Starts Replimune Group (REPL) at Overweight
Tweet
Share
E-mailGet Alerts REPL Hot Sheet
Price: $8.62 +1.77%
Rating Summary:
4 Buy, 7 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Rating Summary:
4 Buy, 7 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Join SI Premium – FREE
Barclays analyst Peter Lawson initiates coverage on Replimune Group (NASDAQ: REPL) with a Overweight rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Replimune Group click here. For more ratings news on Replimune Group click here.
Shares of Replimune Group closed at $16.21 yesterday.
You May Also Be Interested In
- Deutsche Bank Starts Alzchem Group AG (ACT:GR) at Buy
- RBC Capital Starts Natera (NTRA) at Outperform
- KeyBanc Starts Phinia Inc. (PHIN) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
